Fate Therapeutics (NQ: FATE )
4.560
+0.290
(+6.79%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2024
Add to My Watchlist
All News about Fate Therapeutics
Fate Therapeutics Initiated With Hold Rating - Read Why
July 28, 2022
Via Benzinga
Via Benzinga
Via Benzinga
Via Benzinga
2 Natural-Killer Cell Therapy Oncology Companies Investors Should Watch
February 08, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|